The high dose (10 mg/kg) of ADC SAR408701 analog suppressed A549 tumor growth (51% TGI) even in the absence of expressed CEACAM5, but anti-CEACAM5 CAR-T displayed no tumor growth inhibition (Figures 4F, G). Here, CEACAM5 is linked to neoplasm.